CH624407A5 - - Google Patents

Download PDF

Info

Publication number
CH624407A5
CH624407A5 CH596979A CH596979A CH624407A5 CH 624407 A5 CH624407 A5 CH 624407A5 CH 596979 A CH596979 A CH 596979A CH 596979 A CH596979 A CH 596979A CH 624407 A5 CH624407 A5 CH 624407A5
Authority
CH
Switzerland
Prior art keywords
formula
group
compound
carbon atoms
alkyl
Prior art date
Application number
CH596979A
Other languages
German (de)
English (en)
Inventor
Victor John Bauer
Raymond Walter Kosley
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of CH624407A5 publication Critical patent/CH624407A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/52Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03CPHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
    • G03C1/00Photosensitive materials
    • G03C1/685Compositions containing spiro-condensed pyran compounds or derivatives thereof, as photosensitive substances

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH596979A 1973-12-12 1979-06-26 CH624407A5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/424,080 US3962259A (en) 1973-12-12 1973-12-12 1,3-Dihydrospiro[isobenzofuran]s and derivatives thereof

Publications (1)

Publication Number Publication Date
CH624407A5 true CH624407A5 (es) 1981-07-31

Family

ID=23681366

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1646974A CH620214A5 (es) 1973-12-12 1974-12-11
CH596979A CH624407A5 (es) 1973-12-12 1979-06-26

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH1646974A CH620214A5 (es) 1973-12-12 1974-12-11

Country Status (14)

Country Link
US (2) US3962259A (es)
JP (1) JPS5089363A (es)
AT (2) AT352125B (es)
BE (1) BE823279A (es)
CA (1) CA1051886A (es)
CH (2) CH620214A5 (es)
DE (1) DE2458176A1 (es)
DK (1) DK142055B (es)
FR (1) FR2254332B1 (es)
GB (1) GB1495286A (es)
IE (1) IE40297B1 (es)
IL (1) IL46202A (es)
LU (1) LU71460A1 (es)
NL (1) NL7415940A (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0139138A1 (en) * 1983-08-25 1985-05-02 Hoechst-Roussel Pharmaceuticals Incorporated Spiro(benzofuran-azalkanes), a method for their preparation and their use as medicaments

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
US4166120A (en) * 1978-04-14 1979-08-28 American Hoechst Corporation Analgesic and tranquilizing benzoylpropyl-spiro[dihydrobenzofuran]piperidines and pyrrolidines
US4166119A (en) * 1978-04-14 1979-08-28 American Hoechst Corporation Analgesic and tranquilizing spiro[dihydrobenzofuran]piperidines and pyrrolidines
US4301292A (en) * 1979-09-06 1981-11-17 Hoechst-Roussel Pharmaceuticals, Incorporated 1-[2-(4,5-Dihydro-4,4-dialkyl-2-oxazolyl)phenyl]-4-(dialkylamino)cyclohexanol
US4263317A (en) * 1979-09-06 1981-04-21 Hoechst-Roussel Pharmaceuticals, Inc. Spiro[cyclohexane-1,1'(3'H)-isobenzofuran]s
US4268515A (en) * 1980-02-04 1981-05-19 Hoechst-Roussel Pharmaceuticals Inc. Spiro[dihydrobenzofuran-piperidines and-pyrrolidines], pharmaceutical compositions thereof and methods of use thereof
FR2519636A2 (en) * 1982-01-14 1983-07-18 Delalande Sa Spiro iso:benzofuran and iso:benzothiophene derivs. - with anticonvulsant and analgesic activities
FR2498603A1 (fr) * 1981-01-29 1982-07-30 Delalande Sa Nouveaux derives spiro-1 isobenzofuranniques et spiro-1 isobenzothiopheniques, leur procede de preparation et leur application en therapeutique
US4374137A (en) * 1981-08-07 1983-02-15 Hoechst-Roussel Pharmaceuticals Inc. Spiro[benzofuranisoquinoline]s and their use as pharmaceuticals
US5206240A (en) * 1989-12-08 1993-04-27 Merck & Co., Inc. Nitrogen-containing spirocycles
IL96507A0 (en) * 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
EP0450761A1 (en) * 1990-03-02 1991-10-09 Merck & Co. Inc. Spirocyclic oxytocin antagonists
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
US5648352A (en) * 1991-09-13 1997-07-15 Merck & Co., Inc. Piperazinylcamphorsulfonyl oxytocin antagonists
US5693643A (en) * 1991-09-16 1997-12-02 Merck & Co., Inc. Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
DK78692D0 (da) * 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
US5239110A (en) * 1992-12-30 1993-08-24 Sterling Winthrop, Inc. Phenylcyclohexanol derivatives as agents for treating CNS disorders
AU2223495A (en) * 1994-04-15 1995-11-10 Yamanouchi Pharmaceutical Co., Ltd. Spiro compound and medicinal composition thereof
US6017919A (en) * 1996-02-06 2000-01-25 Japan Tobacco Inc. Compounds and pharmaceutical use thereof
US6374762B1 (en) * 1997-10-27 2002-04-23 Correct Craft, Inc. Water sport towing apparatus
AU9646298A (en) 1997-10-27 1999-05-17 Sumitomo Pharmaceuticals Company, Limited Amide derivatives
US6166209A (en) * 1997-12-11 2000-12-26 Hoffmann-La Roche Inc. Piperidine derivatives
WO2000064859A1 (fr) * 1999-04-21 2000-11-02 Sumitomo Pharmaceuticals Co., Ltd. Derives d'amide
AU3679800A (en) * 1999-04-23 2000-11-10 Sumitomo Pharmaceuticals Company, Limited Apoptosis inhibitors
WO2002034719A1 (fr) * 2000-04-21 2002-05-02 Sankyo Company, Limited Composes heterocycliques azotes satures
US20030078278A1 (en) * 2001-06-26 2003-04-24 Pfizer Inc. Spiropiperidine compounds as ligands for ORL-1 receptor
RU2007109794A (ru) * 2004-08-19 2008-09-27 Вертекс Фармасьютикалз, Инкорпорейтед (Us) Модуляторы мускариновых рецепторов
US7786141B2 (en) * 2004-08-19 2010-08-31 Vertex Pharmaceuticals Incorporated Dihydrospiroindene modulators of muscarinic receptors
RU2007124373A (ru) * 2004-11-29 2009-01-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) Модуляторы мускариновых рецептеров
WO2007028638A1 (en) * 2005-09-09 2007-03-15 Euro-Celtique S.A. Fused and spirocycle compounds and the use thereof
WO2007076070A2 (en) * 2005-12-22 2007-07-05 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
ATE517106T1 (de) * 2006-02-22 2011-08-15 Vertex Pharma Kondensierte spiropiperidine als modulatoren muskarinartiger rezeptoren
WO2007100664A2 (en) * 2006-02-22 2007-09-07 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
EP1847542A1 (en) * 2006-04-21 2007-10-24 Laboratorios del Dr. Esteve S.A. Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor
AU2007269863A1 (en) * 2006-06-29 2008-01-10 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
EP2051712A2 (en) * 2006-08-15 2009-04-29 Vertex Pharmceuticals Incorporated Modulators of muscarinic receptors
AU2007284350A1 (en) * 2006-08-18 2008-02-21 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
EP2207549A1 (en) * 2007-10-03 2010-07-21 Vertex Pharmceuticals Incorporated Modulators of muscarinic receptors
WO2011137024A1 (en) * 2010-04-26 2011-11-03 Merck Sharp & Dohme Corp. Novel spiropiperidine prolylcarboxypeptidase inhibitors
TW201643169A (zh) 2010-07-09 2016-12-16 艾伯維股份有限公司 作為s1p調節劑的螺-哌啶衍生物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3686186A (en) * 1970-10-05 1972-08-22 William J Houlihan Substituted isochroman or phthalan piperidenes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0139138A1 (en) * 1983-08-25 1985-05-02 Hoechst-Roussel Pharmaceuticals Incorporated Spiro(benzofuran-azalkanes), a method for their preparation and their use as medicaments

Also Published As

Publication number Publication date
DK142055C (es) 1981-01-12
DE2458176A1 (de) 1975-06-26
LU71460A1 (es) 1976-11-11
FR2254332B1 (es) 1978-07-21
CH620214A5 (es) 1980-11-14
GB1495286A (en) 1977-12-14
US3962259A (en) 1976-06-08
BE823279A (es) 1975-06-12
CA1051886A (en) 1979-04-03
IL46202A0 (en) 1975-03-13
IE40297L (en) 1975-06-12
ATA812377A (de) 1981-05-15
ATA988374A (de) 1979-02-15
IL46202A (en) 1980-02-29
AT352125B (de) 1979-09-10
IE40297B1 (en) 1979-04-25
US3985889A (en) 1976-10-12
DK142055B (da) 1980-08-18
AT365191B (de) 1981-12-28
FR2254332A1 (es) 1975-07-11
JPS5089363A (es) 1975-07-17
NL7415940A (nl) 1975-06-16
DK645074A (es) 1975-08-18

Similar Documents

Publication Publication Date Title
CH624407A5 (es)
CH619228A5 (es)
DE69231854T2 (de) Substituierte (s)-3-phenylpiperidin derivate, deren herstellung und deren verwendung als dopamin autorezeptor antagonisten
DE69106365T2 (de) Chinuclidinderivate.
EP0004952B1 (de) Spiro-(dihydrobenzofuranpiperidine und -pyrrolidine) und deren Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung für Arzneimittel
DE69826891T2 (de) Piperidinderivate
CH462835A (de) Verfahren zur Herstellung von neuen Triazaspirodecanen und ihren Säureadditionssalzen
EP1015433B1 (de) Substituierte 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0004951A1 (de) N-(3-Benzoyl-propyl)-spiro-(dihydrobenzofuranpiperidine und -pyrrolidine) und Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung für Arzneimittel
DE2362754C2 (de) Cyclopropylalkylaminoreste enthaltende Oxazolinverbindungen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2514914A1 (de) Verfahren zur herstellung tertiaerer amine
DE2314639A1 (de) Pharmakodynamisch aktive aminoalkyloximaether
DE2840786C2 (es)
DE2816380A1 (de) Spiro eckige klammer auf indolin- 3,4'-piperidine eckige klammer zu und verwandte verbindungen
DD153550A5 (de) Verfahren zur herstellung von neuer 1,2,4-oxadiazolin-5-on-derivaten
EP0123998A2 (de) 4-Phenyl-tetrahydro-furano-pyridine, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen
DE1052403B (de) Verfahren zur Herstellung von in 3-Stellung substituierten 10-{[1'-Methylpiperidyl-(4
AT347459B (de) Verfahren zur herstellung von neuen substi- tuierten 1,3-dihydrospiro(isobenzofuranen) sowie von optischen antipoden und saeure- additionssalzen dieser verbindungen
DE2233088A1 (de) Benzomorphanderivate
AT253507B (de) Verfahren zur Herstellung von neuen Triazaspiro-(4,5)-decanen und ihren Säureadditionssalzen
DE1645901C3 (de) gamma-(4-Alkylp!peridino)-p-fluorbutyrophenone und Verfahren zu ihrer Herstellung
DE1445729A1 (de) Verfahren zur Herstellung von Hexahydro-1-aryl-3-imino-3H-oxazolo-[3,4-a]pyridinen
DE1568104B2 (de) Tricyclische n-alkylierte derivate des acetamids und verfahren zu ihrer herstellung
DE2264903A1 (de) Piperidinderivate
CH613452A5 (en) Process for the preparation of novel tetrahydropyridine derivatives

Legal Events

Date Code Title Description
PL Patent ceased